Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daolin Tang

Showing results (51-60 of 418) with videos related to

Pageof 42
Sort By:
The FEBS Journal|June 6, 2021
Signaling pathways and defense mechanisms of ferroptosisJiao Liu, Rui Kang, Daolin Tang
Cancer Gene Therapy|November 15, 2023
Correction: The KRAS-G12C inhibitor: activity and resistanceJiao Liu, Rui Kang, Daolin Tang
Cells|April 13, 2026
SQSTM1/p62 at the Crossroads of Autophagy, Inflammation, and Lethal InfectionRuoxi Zhang, Rui Kang, Daolin Tang
Journal of Intensive Medicine|February 15, 2023
Mitochondrial ACOD1/IRG1 in infection and sterile inflammationRunliu Wu, Rui Kang, Daolin Tang
Cancer Gene Therapy|July 17, 2020
ESCRT-III-mediated membrane repair in cell death and tumor resistanceJiao Liu, Rui Kang, Daolin Tang
Cancer Gene Therapy|April 4, 2023
Reductive cell death: the other side of the coinRuoxi Zhang, Rui Kang, Daolin Tang
Hepatology (Baltimore, Md.)|April 4, 2023
Ferroptosis in hepatocellular carcinoma: from bench to bedsideDaolin Tang, Guido Kroemer, Rui Kang
Cancer Research|January 26, 2024
Gut Microbiome Mediates Ferroptosis Resistance for Colorectal Cancer DevelopmentRuoxi Zhang, Rui Kang, Daolin Tang
Trends in Cancer|January 21, 2024
Adverse effects of ferroptotic therapy: mechanisms and managementJiao Liu, Rui Kang, Daolin Tang
Trends in Pharmacological Sciences|June 12, 2024
Targeting GPX4 in ferroptosis and cancer: chemical strategies and challengesJiao Liu, Daolin Tang, Rui Kang
Pageof 42

Showing results (51-60 of 418) with videos related to

Sort By:
Pageof 42
The FEBS Journal|June 6, 2021
Signaling pathways and defense mechanisms of ferroptosisJiao Liu, Rui Kang, Daolin Tang
Cancer Gene Therapy|November 15, 2023
Correction: The KRAS-G12C inhibitor: activity and resistanceJiao Liu, Rui Kang, Daolin Tang
Cells|April 13, 2026
SQSTM1/p62 at the Crossroads of Autophagy, Inflammation, and Lethal InfectionRuoxi Zhang, Rui Kang, Daolin Tang
Journal of Intensive Medicine|February 15, 2023
Mitochondrial ACOD1/IRG1 in infection and sterile inflammationRunliu Wu, Rui Kang, Daolin Tang
Cancer Gene Therapy|July 17, 2020
ESCRT-III-mediated membrane repair in cell death and tumor resistanceJiao Liu, Rui Kang, Daolin Tang
Cancer Gene Therapy|April 4, 2023
Reductive cell death: the other side of the coinRuoxi Zhang, Rui Kang, Daolin Tang
Hepatology (Baltimore, Md.)|April 4, 2023
Ferroptosis in hepatocellular carcinoma: from bench to bedsideDaolin Tang, Guido Kroemer, Rui Kang
Cancer Research|January 26, 2024
Gut Microbiome Mediates Ferroptosis Resistance for Colorectal Cancer DevelopmentRuoxi Zhang, Rui Kang, Daolin Tang
Trends in Cancer|January 21, 2024
Adverse effects of ferroptotic therapy: mechanisms and managementJiao Liu, Rui Kang, Daolin Tang
Trends in Pharmacological Sciences|June 12, 2024
Targeting GPX4 in ferroptosis and cancer: chemical strategies and challengesJiao Liu, Daolin Tang, Rui Kang
Pageof 42